⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL788204 | 1.00 | — | — | |
| SCHEMBL321306 | 1.00 | — | — | |
| SCHEMBL788740 | 1.00 | — | — | |
| SCHEMBL5074216 | 1.00 | — | — | |
| SCHEMBL798364 | 1.00 | — | — | |
| SCHEMBL322266 | 1.00 | — | — | |
| SCHEMBL322259 | 0.97 | — | — | |
| SCHEMBL185817 | 0.88 | — | — | |
| SCHEMBL17675714 | 0.85 | — | — | |
| SCHEMBL185215 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240156846-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS | NATIONAL INSTITUTES OF HEALTH | 2024-05-16 | — | — | US | claimed |
| US-11939588-B2 | Elevated resistance to insects and plant pathogens without compromising seed production | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2024-03-26 | — | — | US | claimed |
| EP-3812464-A1 | ELEVATED RESISTANCE TO INSECTS AND PLANT PATHOGENS WITHOUT COMPROMISING SEED PRODUCTION | Board of Trustees of Michigan State University (US) | 2021-04-28 | — | — | EP | claimed |
| US-20210115464-A1 | ELEVATED RESISTANCE TO INSECTS AND PLANT PATHOGENS WITHOUT COMPROMISING SEED PRODUCTION | UNITED STATES DEPARTMENT OF ENERGY | 2021-04-22 | — | — | US | claimed |
| EP-1313377-B1 | TREATMENT OF HELICOBACTER WITH ISOTHIOCYANATES | FAHEY JED W (US) | 2015-01-21 | — | — | EP | claimed |
| EP-2257630-A2 | BIOSYNTHETIC ENGINEERING OF GLUCOSINOLATES | University of Copenhagen (DK) | 2010-12-08 | — | — | EP | claimed |
| US-20090326056-A1 | NOVEL ACTIVES AGAINST PROSTATE CARCINOMA | DSM IP ASSETS B.V. (NL) | 2009-12-31 | — | — | US | claimed |
| WO-2009106985-A2 | BIOSYNTHETIC ENGINEERING OF GLUCOSINOLATES | UNIVERSITY OF COPENHAGEN (DK) | 2009-09-03 | — | — | WO | claimed |
| EP-1569628-B1 | NOVEL USE OF LYCOPENE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ANDROGEN SIGNALLING | DSM IP ASSETS BV (NL) | 2009-07-22 | — | — | EP | claimed |
| CN-101442995-A | Novel actives against prostate carcinoma | DSM IP ASSETS BV (NL) | 2009-05-27 | — | — | CN | claimed |
| EP-2020997-A2 | NOVEL ACTIVES AGAINST PROSTATE CARCINOMA | DSMIP Assets B.V. (NL) | 2009-02-11 | — | — | EP | claimed |
| WO-2007131767-A2 | NOVEL ACTIVES AGAINST PROSTATE CARCINOMA | DSM IP ASSETS B.V. (NL) | 2007-11-22 | — | — | WO | claimed |
| US-20060069151-A1 | Novel use of lycopene | DSM IP ASSETS B.V. (NL) | 2006-03-30 | — | — | US | claimed |
| US-20060020046-A1 | Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies | DMS IP ASSETS B.V. (NL) | 2006-01-26 | — | — | US | claimed |
| CN-1720030-A | The new purposes of lycopene | DSM IP ASSETS BV (NL) | 2006-01-11 | — | — | CN | claimed |
| EP-1569628-A1 | NOVEL USE OF LYCOPENE | DSM IP Assets B.V. (NL) | 2005-09-07 | — | — | EP | claimed |
| EP-1476143-A1 | COMPOSITIONS COMPRISING LYCOPENE FOR THE TREATMENT AND PREVENTION OF ANGIOGENESIS ASSOCIATED PATHOLOGIES | DSM IP Assets B.V. (NL) | 2004-11-17 | — | — | EP | claimed |
| WO-2004052351-A1 | NOVEL USE OF LYCOPENE | DSM IP ASSETS B.V. (CH) | 2004-06-24 | — | — | WO | claimed |
| WO-2003068202-A1 | COMPOSITIONS COMPRISING LYCOPENE FOR THE TREATMENT AND PREVENTION OF ANGIOGENESIS ASSOCIATED PATHOLOGIES | DSM IP ASSETS B.V. (NL) | 2003-08-21 | — | — | WO | claimed |
| WO-2024105148-A1 | PLANTS WITH LOW SEED GLUCOSINOLATE CONTENT | UNIVERSITY OF COPENHAGEN (DK) | 2024-05-23 | — | — | WO | disclosed |
| US-20240156846-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS | NATIONAL INSTITUTES OF HEALTH | 2024-05-16 | — | — | US | disclosed |
| US-20240115626-A1 | COMPOSITIONS AND METHODS TO INCREASE PRODUCTION OF ISOTHIOCYANATES | CHURCH & DWIGHT CO., INC. (US) | 2024-04-11 | — | — | US | disclosed |
| US-11939588-B2 | Elevated resistance to insects and plant pathogens without compromising seed production | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2024-03-26 | — | — | US | disclosed |
| US-11801273-B2 | Compositions and methods to increase production of isothiocyanates | CHURCH & DWIGHT CO., INC. (US) | 2023-10-31 | — | — | US | disclosed |
| WO-2023133494-A2 | OIL-BASED ISOTHIOCYANATE PRODUCTS AND PROCESSES FOR PREPARING OIL-BASED ISOTHIOCYANATE PRODUCTS | BRASSICA PROTECTION PRODUCTS LLC (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2022140409-A1 | COMPOSITIONS AND METHODS TO INCREASE PRODUCTION OF ISOTHIOCYANATES | CHURCH & DWIGHT CO., INC. (US) | 2022-06-30 | — | — | WO | disclosed |
| US-20220193152-A1 | COMPOSITIONS AND METHODS TO INCREASE PRODUCTION OF ISOTHIOCYANATES | CHURCH & DWIGHT CO., INC. (US) | 2022-06-23 | — | — | US | disclosed |
| CN-112469279-B | Fungicides for the prevention and control of fungal pathogens | 洛桑大学 | 2022-05-31 | — | — | CN | disclosed |
| US-20220160802-A1 | METHODS AND COMPOSITIONS FOR PROMOTING HEALTH IN A SUBJECT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2022-05-26 | — | — | US | disclosed |
| CN-114208848-A | Corn growth regulator containing chitosan and preparation and use methods thereof | 安徽科技学院 | 2022-03-22 | — | — | CN | disclosed |
| EP-3820290-A1 | FUNGICIDES TO PREVENT AND CONTROL FUNGAL PATHOGENS | Université de Lausanne (CH) | 2021-05-19 | — | — | EP | disclosed |
| EP-3812464-A1 | ELEVATED RESISTANCE TO INSECTS AND PLANT PATHOGENS WITHOUT COMPROMISING SEED PRODUCTION | Board of Trustees of Michigan State University (US) | 2021-04-28 | — | — | EP | disclosed |
| US-20210115464-A1 | ELEVATED RESISTANCE TO INSECTS AND PLANT PATHOGENS WITHOUT COMPROMISING SEED PRODUCTION | UNITED STATES DEPARTMENT OF ENERGY | 2021-04-22 | — | — | US | disclosed |
| CN-112469279-A | Fungicides for the prevention and control of fungal pathogens | 洛桑大学 | 2021-03-09 | — | — | CN | disclosed |
| US-20200255872-A1 | Isothiocyanate containing Brassicaceae Products and Method of Preparation Thereof | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2020-08-13 | — | — | US | disclosed |
| WO-2020011750-A1 | FUNGICIDES TO PREVENT AND CONTROL FUNGAL PATHOGENS | Université de Lausanne (CH) | 2020-01-16 | — | — | WO | disclosed |
| US-20190046530-A1 | PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION, APOPTOSIS AND STRESS | KONSTANTOPOULOS KONSTANTINOS (US) | 2019-02-14 | — | — | US | disclosed |
| US-20180203014-A1 | COMPOSITIONS FOR DETECTING CIRCULATING INTEGRIN BETA-3 BIOMARKER AND METHODS FOR DETECTING CANCERS AND ASSESSING TUMOR PRESENCE OR PROGRESSION, CANCER DRUG RESISTANCE AND TUMOR STEMNESS | UNIV CALIFORNIA (US) | 2018-07-19 | — | — | US | disclosed |
| US-9903855-B2 | Assays for screening for or identifying an agent or molecule that can block or inhibit AVB3 integrin from forming a complex with KRAS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-02-27 | — | — | US | disclosed |
| US-9632074-B2 | Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-04-25 | — | — | US | disclosed |
| US-9610258-B2 | Methods of stabilizing the extracellular matrix and compositions therefor | MD MATRIX HEALTH LLC (US) | 2017-04-04 | — | — | US | disclosed |
| US-9561272-B2 | Compositions and methods for modulating immune responses | THE UNIVERSITY OF QUEENSLAND (AU) | 2017-02-07 | — | — | US | disclosed |
| US-9453226-B2 | Protection of cells from Alu-RNA-induced degeneration and inhibitors for protecting cells | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2016-09-27 | — | — | US | disclosed |
| US-20160243057-A1 | METHODS OF STABILIZING THE EXTRACELLULAR MATRIX AND COMPOSITIONS THEREFOR | MD MATRIX HEALTH LLC DBA MD MATRIX HEALTH INC (US) | 2016-08-25 | — | — | US | disclosed |
| US-20160146783-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER AND DISEASES AND CONDITIONS RESPONSIVE TO CELL GROWTH INHIBITION | UNIV CALIFORNIA (US) | 2016-05-26 | — | — | US | disclosed |
| EP-2590996-B1 | GLUCOSINOLATE TRANSPORTER PROTEIN AND USES THEREOF | BAYER CROPSCIENCE NV (BE) | 2016-05-25 | — | — | EP | disclosed |
| US-20160038485-A1 | PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION, APOPTOSIS AND STRESS | TALALAY, PAUL | 2016-02-11 | — | — | US | disclosed |
| US-20160015709-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER AND DISEASES AND CONDITIONS RESPONSIVE TO CELL GROWTH INHIBITION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-21 | — | — | US | disclosed |
| US-20150216955-A1 | IMMUNOMODULATORY AGENT AND USES THEREFOR | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-08-06 | — | — | US | disclosed |
| US-20150202285-A1 | COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-07-23 | — | — | US | disclosed |
| US-9017697-B2 | Compositions and methods for modulating immune responses | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-04-28 | — | — | US | disclosed |
| US-20150045409-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-02-12 | — | — | US | disclosed |
| EP-1313377-B1 | TREATMENT OF HELICOBACTER WITH ISOTHIOCYANATES | FAHEY JED W (US) | 2015-01-21 | — | — | EP | disclosed |
| US-8927007-B2 | Formulations for treatment with glucosinolates | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-01-06 | — | — | US | disclosed |
| EP-2813493-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | Sumitomo Chemical Company Limited (JP) | 2014-12-17 | — | — | EP | disclosed |
| CN-104114546-A | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL CO | 2014-10-22 | — | — | CN | disclosed |
| US-20140193480-A1 | TOPICAL ANTI-INFLAMMATORY COMPOSITIONS AND USES THEREOF | MD MATRIX HEALTH LLC DBA MD MATRIX HEALTH INC. (US) | 2014-07-10 | — | — | US | disclosed |
| US-20140137294-A1 | GLUCOSINOLATE TRANSPORTER PROTEIN AND USES THEREOF | UNIVERSITY OF COPENHAGEN (DK) | 2014-05-15 | — | — | US | disclosed |
| WO-2013152313-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER AND DISEASES AND CONDITIONS RESPONSIVE TO GROWTH FACTOR INHIBITION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-10-10 | — | — | WO | disclosed |
| EP-2616061-A2 | FORMULATIONS FOR TREATMENT WITH GLUCOSINOLATE | Brassica Protection Products LLC (US) | 2013-07-24 | — | — | EP | disclosed |
| US-20130164365-A1 | FORMULATIONS FOR TREATMENT WITH GLUCOSINOLATES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-06-27 | — | — | US | disclosed |
| CN-103124738-A | Glucosinolate transporter protein and uses thereof | BAYER BIOSCIENCE NV | 2013-05-29 | — | — | CN | disclosed |
| EP-2590996-A2 | GLUCOSINOLATE TRANSPORTER PROTEIN AND USES THEREOF | Bayer CropScience NV (BE) | 2013-05-15 | — | — | EP | disclosed |
| WO-2012142511-A2 | ORTHOMOLECULAR COMPOSITIONS AND THEIR USE IN STABILIZING THE EXTRACELLULAR MATRIX | MD MATRIX HEALTH LLC DBA MD MATRIX HEALTH INC (US) | 2012-10-18 | — | — | WO | disclosed |
| WO-2012037193-A2 | FORMULATIONS FOR TREATMENT WITH GLUCOSINOLATE | BRASSICA PROTECTION PRODUCTS LLC (US) | 2012-03-22 | — | — | WO | disclosed |
| WO-2012004013-A2 | GLUCOSINOLATE TRANSPORTER PROTEIN AND USES THEREOF | BAYER BIOSCIENCE N.V. (BE) | 2012-01-12 | — | — | WO | disclosed |
| US-20100151000-A1 | COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES | THE UNIVERSITY OF QUEENSLAND (AU) | 2010-06-17 | — | — | US | disclosed |
| US-20100015085-A1 | PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION/INFECTION, APOPTOSIS AND STRESS | JOHNS HOPKINS UNIVERSITY | 2010-01-21 | — | — | US | disclosed |
| US-20100011462-A1 | FLAVIN MONOOXYGENASES AND TRANSCRIPTION FACTORS INVOLVED IN GLUCOSINOLATE BIOSYNTHESIS | UNIVERSITY OF COPENHAGEN | 2010-01-14 | — | — | US | disclosed |
| US-20090326056-A1 | NOVEL ACTIVES AGAINST PROSTATE CARCINOMA | DSM IP ASSETS B.V. (NL) | 2009-12-31 | — | — | US | disclosed |
| EP-1569628-B1 | NOVEL USE OF LYCOPENE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ANDROGEN SIGNALLING | DSM IP ASSETS BV (NL) | 2009-07-22 | — | — | EP | disclosed |
| CN-101442995-A | Novel actives against prostate carcinoma | DSM IP ASSETS BV (NL) | 2009-05-27 | — | — | CN | disclosed |
| EP-2057271-A2 | FLAVIN MONOOXYGENASES AND TRANSCRIPTION FACTORS INVOLVED IN GLUCOSINOLATE BIOSYNTHESIS | University of Copenhagen (DK) | 2009-05-13 | — | — | EP | disclosed |
| EP-2020997-A2 | NOVEL ACTIVES AGAINST PROSTATE CARCINOMA | DSMIP Assets B.V. (NL) | 2009-02-11 | — | — | EP | disclosed |
| US-7402569-B2 | Treatment of Helicobacter with isothiocyanates | BRASSICA FOUNDATION FOR CHEMOPROTECTION RESEARCH, INC. (US) | 2008-07-22 | — | — | US | disclosed |
| US-20080131578-A1 | FOOD OR DRINK PRODUCTS, SUPPLEMENTS OR ADDITIVES PRODUCED FROM HIGH GLUCORAPHANIN-CONTAINING BROCCOLI VARIETY 'HOPKINS' | Caudill Seed and Warehouse Company, Inc. | 2008-06-05 | — | — | US | disclosed |
| WO-2008023263-A2 | FLAVIN MONOOXYGENASES AND TRANSCRIPTION FACTORS INVOLVED IN GLUCOSINOLATE BIOSYNTHESIS | UNIVERSITY OF COPENHAGEN (DK) | 2008-02-28 | — | — | WO | disclosed |
| WO-2007131767-A2 | NOVEL ACTIVES AGAINST PROSTATE CARCINOMA | DSM IP ASSETS B.V. (NL) | 2007-11-22 | — | — | WO | disclosed |
| US-7250559-B2 | Nucleic acids encoding glucosinolate biosynthesis enzymes and methods of their use | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-07-31 | — | — | US | disclosed |
| WO-2006065736-A2 | METHOD OF EXTRACTION OF ISOTHIOCYANATES INTO OIL FROM GLUCOSINOLSATE-CONTAINING PLANTS | JOHNS HOPKINS UNIVERSITY (US) | 2006-06-22 | — | — | WO | disclosed |
| US-20060127996-A1 | Method of extraction of isothiocyanates into oil from glucosinolate-containing plants and method of producing products with oil containing isothiocyanates extracted from glucosinolate-containing plants | JOHNS HOPKINS UNIVERSITY | 2006-06-15 | — | — | US | disclosed |
| US-20060069151-A1 | Novel use of lycopene | DSM IP ASSETS B.V. (NL) | 2006-03-30 | — | — | US | disclosed |
| US-20060020046-A1 | Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies | DMS IP ASSETS B.V. (NL) | 2006-01-26 | — | — | US | disclosed |
| CN-1720030-A | The new purposes of lycopene | DSM IP ASSETS BV (NL) | 2006-01-11 | — | — | CN | disclosed |
| US-6977297-B1 | Methods and means for modification of glucosinolates in plants | PLANT BIOSCIENCE LIMITED (GB) | 2005-12-20 | — | — | US | disclosed |
| EP-1569628-A1 | NOVEL USE OF LYCOPENE | DSM IP Assets B.V. (NL) | 2005-09-07 | — | — | EP | disclosed |
| US-20050055744-A1 | Nucleic acids encoding glucosinolate biosynthesis enzymes and methods of their use | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2005-03-10 | — | — | US | disclosed |
| EP-1476143-A1 | COMPOSITIONS COMPRISING LYCOPENE FOR THE TREATMENT AND PREVENTION OF ANGIOGENESIS ASSOCIATED PATHOLOGIES | DSM IP Assets B.V. (NL) | 2004-11-17 | — | — | EP | disclosed |
| US-20040180843-A1 | Treatment of helicobacter with isothocyanates | BRASSICA FOUNDATION FOR CHEMOPROTECTION RESEARCH, INC. | 2004-09-16 | — | — | US | disclosed |
| WO-2004052351-A1 | NOVEL USE OF LYCOPENE | DSM IP ASSETS B.V. (CH) | 2004-06-24 | — | — | WO | disclosed |
| US-6737441-B2 | PREVENTING OR TREATING PERSISTENT CHRONIC GASTRITIS, ULCERS AND/OR STOMACH CANCER | Fahey, Jed W. | 2004-05-18 | — | — | US | disclosed |
| WO-2003068202-A1 | COMPOSITIONS COMPRISING LYCOPENE FOR THE TREATMENT AND PREVENTION OF ANGIOGENESIS ASSOCIATED PATHOLOGIES | DSM IP ASSETS B.V. (NL) | 2003-08-21 | — | — | WO | disclosed |
| EP-1313377-A2 | TREATMENT OF HELICOBACTER WITH ISOTHIOCYANATES | Fahey, Jed W. (US) | 2003-05-28 | — | — | EP | disclosed |
| WO-2003012088-A2 | NUCLEIC ACID MOLECULES ENCODING A GLUCOSINOLATE SULFATASE | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSCNSCHAFTEN E.V. (DE) | 2003-02-13 | — | — | WO | disclosed |
| WO-2003004619-A2 | NUCLEIC ACIDS ENCODING GLUCOSINOLATE BIOSYNTHESIS ENZYMES AND METHODS OF THEIR USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-01-16 | — | — | WO | disclosed |
| US-20020151505-A1 | Treatment of helicobacter with isothiocyanates | FAHEY, JED W. | 2002-10-17 | — | — | US | disclosed |
| WO-2002015722-A2 | TREATMENT OF HELICOBACTER WITH ISOTHIOCYANATES | FAHEY JED W (US) | 2002-02-28 | — | — | WO | disclosed |
| EP-1032691-A1 | METHODS AND MEANS FOR MODIFICATION OF GLUCOSINOLATES IN PLANTS | Plant Bioscience Limited (GB) | 2000-09-06 | — | — | EP | disclosed |
| WO-1999027120-A1 | METHODS AND MEANS FOR MODIFICATION OF GLUCOSINOLATES IN PLANTS | PLANT BIOSCIENCE LIMITED (GB) | 1999-06-03 | — | — | WO | disclosed |
| WO-1999027120-A1 | METHODS AND MEANS FOR MODIFICATION OF GLUCOSINOLATES IN PLANTS | PLANT BIOSCIENCE LIMITED (GB) | 1999-06-03 | — | — | WO | disclosed |